Stoke Therapeutics, Inc. (STOK)
35.48
+0.83
(+2.40%)
USD |
NASDAQ |
Mar 06, 16:00
35.50
+0.02
(+0.06%)
After-Hours: 20:00
Stoke Therapeutics SG&A Expense (TTM) : 58.79M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.434B |
| Krystal Biotech, Inc. | 146.91M |
| Scholar Rock Holding Corp. | 131.18M |
| Zymeworks, Inc. | 46.08M |
| Moderna, Inc. | 1.018B |